Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Wednesday, Benzinga reports. They presently have a $17.00 target price on the biopharmaceutical company’s stock.
Palatin Technologies Stock Down 3.7 %
NYSEAMERICAN PTN opened at $1.57 on Wednesday. Palatin Technologies has a 52 week low of $1.29 and a 52 week high of $5.65. The firm has a market cap of $30.41 million, a price-to-earnings ratio of -0.63 and a beta of 1.01.
Institutional Investors Weigh In On Palatin Technologies
A hedge fund recently bought a new stake in Palatin Technologies stock. Armistice Capital LLC purchased a new position in Palatin Technologies, Inc. (NYSEAMERICAN:PTN – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 590,000 shares of the biopharmaceutical company’s stock, valued at approximately $2,348,000. Armistice Capital LLC owned about 4.29% of Palatin Technologies at the end of the most recent quarter. Institutional investors and hedge funds own 11.50% of the company’s stock.
Palatin Technologies Company Profile
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
See Also
- Five stocks we like better than Palatin Technologies
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Does A&F’s Q2 Earnings Win Point to a Strong Holiday Season?
- Comparing and Trading High PE Ratio Stocks
- Best Buy Stock Flashes Bullish Signal, Challenges Remain
- Retail Stocks Investing, Explained
- Affirm Shows Buy-Now-Pay-Later Is Here to Stay in Latest Results
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.